<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01401270</url>
  </required_header>
  <id_info>
    <org_study_id>10-256-2</org_study_id>
    <secondary_id>R01DA013444</secondary_id>
    <nct_id>NCT01401270</nct_id>
  </id_info>
  <brief_title>Prize Contingency Management for Cocaine-Dependent Methadone Patients</brief_title>
  <official_title>Prize Contingency Management for Cocaine-Dependent Methadone Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>UConn Health</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute on Drug Abuse (NIDA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>UConn Health</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators will randomize 300 cocaine-dependent methadone patients to 1 of 6&#xD;
      conditions: (a) a control group, (b) a contingency management condition that arranges a 100%&#xD;
      probability of winning a prize with each draw and has 3 prize categories, (c) a contingency&#xD;
      management condition that arranges a 31% probability of winning and has 3 prize categories,&#xD;
      (d) a contingency management condition that arranges a 100% probability of winning and has 7&#xD;
      prize categories, (e) a contingency management condition that arranges a 31% probability of&#xD;
      winning and has 7 prize categories, or (f) usual prize contingency management with a 50%&#xD;
      probability of winning from 3 prize categories. Magnitudes of reinforcement will be identical&#xD;
      across conditions, but lower overall probability conditions arrange for greater chances of&#xD;
      winning larger magnitude prizes. The investigators expect that the new contingency management&#xD;
      conditions will reduce cocaine use relative to the control condition, that 31% probability&#xD;
      conditions will decrease drug use relative to 100% conditions, and that 7-prize category&#xD;
      conditions will reduce drug use compared to 3-prize category conditions. In addition, the&#xD;
      31%/7-category condition is expected to be most efficacious. Results will be instrumental for&#xD;
      further developing prize contingency management to improve outcomes of cocaine-dependent&#xD;
      methadone patients.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">November 2011</start_date>
  <completion_date type="Actual">May 2018</completion_date>
  <primary_completion_date type="Actual">May 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>longest continuous period of cocaine abstinence</measure>
    <time_frame>three months</time_frame>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">280</enrollment>
  <condition>Cocaine Abuse</condition>
  <arm_group>
    <arm_group_label>Treatment Group A</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Standard Care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100% probability of winning a prize with each draw and has 3 prize categories</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment Group C</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>31% probability of winning and has 3 prize categories</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment Group D</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>100% probability of winning and has 7 prize categories</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment Group E</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>31% probability of winning and has 7 prize categories</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment Group F</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>usual prize contingency management with a 50% probability of winning from 3 prize categories</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>prize contingency management</intervention_name>
    <description>Participants earn the chance to win prizes for the targeted behavior, cocaine abstinence.</description>
    <arm_group_label>Treatment Group B</arm_group_label>
    <arm_group_label>Treatment Group C</arm_group_label>
    <arm_group_label>Treatment Group D</arm_group_label>
    <arm_group_label>Treatment Group E</arm_group_label>
    <arm_group_label>Treatment Group F</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age &gt; 18 years&#xD;
&#xD;
          -  current DSM-IV diagnosis of cocaine dependence&#xD;
&#xD;
          -  enrolled at the clinic for &gt;3 months&#xD;
&#xD;
          -  on a stable dose of methadone (no changes) for &gt;1 month and not requesting a dose&#xD;
             alteration&#xD;
&#xD;
          -  submitted &gt;1 clinic cocaine positive sample in the last 6 months&#xD;
&#xD;
          -  English speaking&#xD;
&#xD;
          -  pass a quiz related to understanding the informed consent form&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  serious, uncontrolled psychiatric illness&#xD;
&#xD;
          -  significant cognitive impairment&#xD;
&#xD;
          -  in recovery from pathological gambling&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sheila M Alessi, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>UConn Health</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Connecticut Health Center</name>
      <address>
        <city>Farmington</city>
        <state>Connecticut</state>
        <zip>06030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>July 22, 2011</study_first_submitted>
  <study_first_submitted_qc>July 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 25, 2011</study_first_posted>
  <last_update_submitted>March 11, 2019</last_update_submitted>
  <last_update_submitted_qc>March 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>UConn Health</investigator_affiliation>
    <investigator_full_name>Sheila Alessi</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cocaine-Related Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

